Literature DB >> 16160505

Characteristics of Pseudomonas corneal infection related to orthokeratology.

Kaoru Araki-Sasaki1, Isao Nishi, Nami Yonemura, Hiromi Takatsuka, Koki Mutoh, Koki Matsumoto, Seishi Asari, Hidenobu Tanihara.   

Abstract

PURPOSE: To describe a Pseudomonas aeruginosa corneal infection resulting from orthokeratology.
METHODS: Case report.
RESULTS: A 17-year-old boy wearing orthokeratology (OK) lenses was referred to our clinic because of redness in his right eye in spite of his usage of ofloxacin (OFLX) eye drops. An excavated paracentral corneal ulcer with an immune ring and hypopyon was observed. It was positioned under the paracentral steeper portion of the optic of the OK lens. Culture of the lens solution revealed P. aeruginosa. The patient was treated with topical OFLX and cefmenoxime (CMX) plus intravenous and subconjunctival injections of cefozopran (CZOP), successfully. The antibiotic susceptibility of P. aeruginosa by the disk diffusion susceptibility test was reduced under moderately hypoxic conditions. Glycocalyx slime was formed on the OK lens in vitro by P. aeruginosa isolated from the case.
CONCLUSIONS: Changes in P. aeruginosa susceptibility to antibiotics under moderately hypoxic conditions and glycocalyx slime formation might affect the features of OK lens-associated infections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16160505     DOI: 10.1097/01.ico.0000175411.05988.fa

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  2 in total

Review 1.  Infectious keratitis and orthokeratology lens use: a systematic review.

Authors:  Ka Wai Kam; Wing Yung; Gabriel Ka Hin Li; Li Jia Chen; Alvin L Young
Journal:  Infection       Date:  2017-05-22       Impact factor: 3.553

2.  Adverse events during 2 years of daily wear of silicone hydrogels in children.

Authors:  Padmaja Sankaridurg; Xiang Chen; Thomas Naduvilath; Percy Lazon de la Jara; Zhi Lin; Li Li; Earl L Smith; Jian Ge; Brien A Holden
Journal:  Optom Vis Sci       Date:  2013-09       Impact factor: 1.973

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.